Acute eculizumab treatment in a pediatric patient with AQP4-IgG+ NMOSD
This case demonstrates the role of eculizumab as a safe and effective treatment option in treating an acute attack of pediatric AQP4+ NMOSD. More data are needed to understand the risk of relapse if transitioning off of these highly effective medications.
Authors
- Logi Rajagopalan
- Lauren Krupp (ORCID: https://orcid.org/0000-0001-7003-807X)
- Ria Soni (ORCID: https://orcid.org/0000-0003-3680-6340)
- Eunhye Oak
- Mekka Garcia
- Kimberly A. O’Neill (ORCID: https://orcid.org/0000-0001-6021-8683)
- Eliana J Applbaum
Institutions
- NYU Langone Health (US)
- New York University (US)
Publication Details
- Journal
- Multiple Sclerosis Journal
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1177/13524585241283650
- Citations
- 5
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 3.99